Institute for Liver Health dba Arizona Liver Health

Chandler, Arizona 85224

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis, Non Alcoholic Steatohepatitis (NASH), Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis

Studies at this site

• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus — Completed